Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
32.46
-0.29 (-0.89%)
Mar 11, 2025, 4:00 PM EST - Market closed
Royalty Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Net Income | 858.98 | 1,135 | 42.83 | 619.73 | 975.04 | Upgrade
|
| Depreciation & Amortization | - | - | 5.67 | 23 | 23.06 | Upgrade
|
| Other Amortization | 19.56 | 20.5 | 21.36 | 20.16 | 11.72 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 615.83 | - | 65.05 | Upgrade
|
| Loss (Gain) From Sale of Investments | -194.46 | -317.98 | 40.26 | 30.21 | -265.67 | Upgrade
|
| Loss (Gain) on Equity Investments | -16.22 | -10.06 | 48.12 | 53.87 | -2.13 | Upgrade
|
| Stock-Based Compensation | 2.34 | 2.36 | 2.17 | 2.44 | 5.43 | Upgrade
|
| Provision & Write-off of Bad Debts | 732.46 | 560.66 | 904.24 | 452.84 | 230.84 | Upgrade
|
| Other Operating Activities | -1,670 | -1,609 | -2,076 | -1,484 | -1,207 | Upgrade
|
| Change in Accounts Receivable | 2,983 | 3,201 | 2,507 | 2,296 | 2,122 | Upgrade
|
| Change in Accounts Payable | -2.29 | 6.24 | 2.29 | -4.59 | -0.77 | Upgrade
|
| Change in Other Net Operating Assets | 55.67 | -0.85 | 30.38 | 8.4 | 76.36 | Upgrade
|
| Operating Cash Flow | 2,769 | 2,988 | 2,144 | 2,018 | 2,035 | Upgrade
|
| Operating Cash Flow Growth | -7.32% | 39.36% | 6.27% | -0.84% | 22.04% | Upgrade
|
| Sale (Purchase) of Intangibles | -2,506 | -2,116 | -1,742 | -2,192 | -2,182 | Upgrade
|
| Investment in Securities | -99.45 | 57.17 | 712.22 | 339.82 | -577.07 | Upgrade
|
| Other Investing Activities | -72.96 | -14.44 | - | -18.6 | - | Upgrade
|
| Investing Cash Flow | -2,678 | -2,073 | -1,029 | -1,870 | -2,759 | Upgrade
|
| Short-Term Debt Issued | - | 350 | - | - | - | Upgrade
|
| Long-Term Debt Issued | 1,471 | - | - | 1,273 | 11,891 | Upgrade
|
| Total Debt Issued | 1,471 | 350 | - | 1,273 | 11,891 | Upgrade
|
| Short-Term Debt Repaid | - | -350 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -1,000 | - | - | -11,210 | Upgrade
|
| Total Debt Repaid | - | -1,350 | - | - | -11,210 | Upgrade
|
| Net Debt Issued (Repaid) | 1,471 | -1,000 | - | 1,273 | 680.63 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 1,150 | Upgrade
|
| Repurchase of Common Stock | -229.65 | -304.76 | - | - | - | Upgrade
|
| Common Dividends Paid | -376.47 | -358.33 | -333.32 | -285.18 | -397.84 | Upgrade
|
| Other Financing Activities | -503.97 | -485.67 | -611.53 | -602.24 | 53.99 | Upgrade
|
| Financing Cash Flow | 361.15 | -2,149 | -944.86 | 385.11 | 1,487 | Upgrade
|
| Net Cash Flow | 452.02 | -1,234 | 169.7 | 532.37 | 762.48 | Upgrade
|
| Free Cash Flow | 2,769 | 2,988 | 2,144 | 2,018 | 2,035 | Upgrade
|
| Free Cash Flow Growth | -7.32% | 39.36% | 6.27% | -0.84% | 22.04% | Upgrade
|
| Free Cash Flow Margin | 122.33% | 126.89% | 95.83% | 88.12% | 95.87% | Upgrade
|
| Free Cash Flow Per Share | 4.66 | 4.96 | 4.90 | 4.86 | 5.42 | Upgrade
|
| Cash Interest Paid | 159.57 | 169.17 | 170.14 | 130.43 | 103.2 | Upgrade
|
| Levered Free Cash Flow | -1,759 | -1,245 | -1,384 | -1,547 | -1,087 | Upgrade
|
| Unlevered Free Cash Flow | -1,637 | -1,149 | -1,288 | -1,463 | -993.85 | Upgrade
|
| Change in Net Working Capital | -58.44 | -31.66 | 131.12 | 190.97 | -122.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.